BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16304576)

  • 1. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.
    Bardenheuer W; Lehmberg K; Rattmann I; Brueckner A; Schneider A; Sorg UR; Seeber S; Moritz T; Flasshove M
    Leukemia; 2005 Dec; 19(12):2281-8. PubMed ID: 16304576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N; Cournoyer D; Momparler RL
    Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model.
    Rattmann I; Kleff V; Sorg UR; Bardenheuer W; Brueckner A; Hilger RA; Opalka B; Seeber S; Flasshove M; Moritz T
    Blood; 2006 Nov; 108(9):2965-71. PubMed ID: 16835384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T; Blau CA
    Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
    J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of the cytidine deaminase cDNA into hematopoietic cells.
    Flasshove M; Frings W; Schröder JK; Moritz T; Schütte J; Seeber S
    Leuk Res; 1999 Nov; 23(11):1047-53. PubMed ID: 10576510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
    Beauséjour CM; Gagnon J; Primeau M; Momparler RL
    Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.
    Brennig S; Rattmann I; Lachmann N; Schambach A; Williams DA; Moritz T
    Cytotherapy; 2012 Apr; 14(4):451-60. PubMed ID: 22242831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
    Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.
    Lachmann N; Brennig S; Phaltane R; Flasshove M; Dilloo D; Moritz T
    Neoplasia; 2013 Mar; 15(3):239-48. PubMed ID: 23479503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK; Kirch C; Flasshove M; Kalweit H; Seidelmann M; Hilger R; Seeber S; Schütte J
    Leukemia; 1996 Dec; 10(12):1919-24. PubMed ID: 8946931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of the best blood compartment to measure cytidine deaminase activity to stratify for optimal gemcitabine or cytarabine treatment.
    Peters GJ; Honeywell RJ; Maulandi M; Giovannetti E; Losekoot N; Etienne-Grimaldi MC; Milano G; Serdjebi C; Ciccolini J;
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):403-12. PubMed ID: 24940698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM; Momparler RL
    Cancer Lett; 1999 Jan; 135(1):29-36. PubMed ID: 10077218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced expression of cytidine deaminase confers sensitivity to capecitabine.
    Morita T; Matsuzaki A; Kurokawa S; Tokue A
    Oncology; 2003; 65(3):267-74. PubMed ID: 14657601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
    Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A; Løvhaug D; Seeberg E; Nordlie EM
    Exp Hematol; 1994 Feb; 22(2):208-14. PubMed ID: 7507861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.